ECO Animal Health forms N. America distribution JV

Pharmgate is the wholly-owned US subsidiary of Jinhe Biotechnology Ltd of China.

 

The venture is called Pharmgate Animal Health LLC and will benefit from the manufacturing and product development experience of its owners to bring to market their ranges of extensively used medicated feed additives and new therapeutic compounds for livestock and poultry, backed by a specialist sales and technical team.

 

ECO Animal Health Group CEO Marc Loomes said: "This is an important step in the global commercialisation of Aivlosin, our novel antibiotic for the treatment of enteric and respiratory disease in swine and poultry.

 

“Pre-approval studies in the US market have shown similar performance of Aivlosin to that seen in markets where the product is already being successfully sold, including Europe, Central and Latin America, China, Japan, South East Asia and Africa.”

 

ECO Animal Health Group develops, registers and markets pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel macrolide antibiotic, Aivlosin, as well as a range of generic therapeutic products.

 

Jinhe Biotechnology Co produces chlortetracycline feed grade, chlortetracycline hydrochloride, salinomycin and other animal health compounds. The company has marketing or supply approvals for these products in most major markets throughout the world.